Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (601-610 of 891) with videos related to

Pageof 90
Sort By:
The American Journal of Medicine|December 1, 1991
Autologous bone marrow transplantation for patients with relapsed Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomasJ M Vose, R L Wahl, M Saleh, et al.
International Immunopharmacology|June 16, 2007
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsRakesh K Singh, Michelle L Varney, Cheryl Leutzinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family membersF J Rutar, S C Augustine, D Colcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based reviewDenise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
JAMA|October 25, 1995
Multiple organ dysfunction syndrome in bone marrow transplantationW D Haire, E I Ruby, B G Gordon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantationW D Haire, E I Ruby, L C Stephens, et al.
Leukemia & Lymphoma|September 18, 2015
Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group ExperienceVijaya R Bhatt, Fausto R Loberiza, Lynette M Smith, et al.
Pageof 90

Showing results (601-610 of 891) with videos related to

Sort By:
Pageof 90
The American Journal of Medicine|December 1, 1991
Autologous bone marrow transplantation for patients with relapsed Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomasJ M Vose, R L Wahl, M Saleh, et al.
International Immunopharmacology|June 16, 2007
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell productsRakesh K Singh, Michelle L Varney, Cheryl Leutzinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family membersF J Rutar, S C Augustine, D Colcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based reviewDenise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
JAMA|October 25, 1995
Multiple organ dysfunction syndrome in bone marrow transplantationW D Haire, E I Ruby, B G Gordon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantationW D Haire, E I Ruby, L C Stephens, et al.
Leukemia & Lymphoma|September 18, 2015
Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group ExperienceVijaya R Bhatt, Fausto R Loberiza, Lynette M Smith, et al.
Pageof 90